PAC-1 T2503
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
PAC-1 has been used in trials studying the treatment of Lymphoma, Melanoma, Solid Tumors, Breast Cancer, and Thoracic Cancers, among others.
CAS nr:
315183-21-2
Purity:
98%
Molecular Weight:
392,49
SMILES:
Oc1c(CC=C)cccc1\C=N\NC(=O)CN1CCN(Cc2ccccc2)CC1
Formula:
C23H28N4O2
Pathway:
Proteases/Proteasome,Apoptosis,Autophagy,Apoptosis
Target:
Caspase,Caspase,Autophagy,Apoptosis
